Intrascleral shunt placement
US10080682B2 · kind B2 · utility
16Cited by
199References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2016 |
| Grant date | Sep 25, 2018 |
| Priority date | — |
| Expiry date | Jun 29, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M37/0069
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Glaucoma can be treated by implanting an intraocular shunt into an eye. The eye has an anterior chamber and sclera. A shunt can be placed into the eye to establish fluid communication from the anterior chamber of the eye through the sclera, and a pharmaceutical or biological agent can be administered to the eye.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.